ctrl K

Price Alert

Black Diamond Therapeutic... (BDTX)

NASDAQ: BDTX · Real-Time Price · USD

2.63

-0.12 (-4.36%)

At close: Aug 19, 2025, 1:53 PM

Black Diamond Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	36.44M	56.22M	34.31M	65.8M
Short-Term Investments	62.14M	75.18M	88.49M	143.99M
Long-Term Investments	n/a	n/a	1.17M	1.22M
Other Long-Term Assets	1.07M	823K	n/a	5.93M
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	2.6M	2.63M	4.9M	n/a
Total Current Assets	101.18M	134.03M	127.71M	209.79M
Property-Plant & Equipment	20.4M	23.71M	27.38M	30.74M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	21.46M	24.53M	28.55M	37.9M
Total Assets	122.64M	158.57M	156.25M	247.68M
Account Payables	4.01M	2.32M	1.88M	4.11M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	16.57M	n/a	n/a	n/a
Total Current Liabilities	20.57M	19.65M	15.26M	23.64M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	18.78M	22.18M	25.3M	28.14M
Total Liabilities	39.35M	41.83M	40.56M	491.5M
Total Debt	22.19M	25.3M	28.14M	28.46M
Common Stock	7K	7K	5K	5K
Retained Earnings	-487.11M	-417.43M	-334.99M	-243.82M
Comprehensive Income	24K	-27K	-1.82M	-414K
Shareholders Equity	83.28M	116.74M	-334.99M	-243.82M
Total Investments	62.14M	75.18M	88.49M	143.99M